Meeting Summary of The NYO3 5th NO-Age/AD Meeting and the 1st Norway-UK Joint Meeting on Aging and Dementia: Recent Progress on the Mechanisms and Interventional Strategies

Research output: Contribution to journalJournal articleResearchpeer-review


  • Fulltext

    Final published version, 6.28 MB, PDF document

  • He Ling Wang
  • Richard Siow
  • Tomas Schmauck-Medina
  • Jianying Zhang
  • Per Morten Sandset
  • Clare Filshie
  • Øystein Lund
  • Linda Partridge
  • Linda Hildegard Bergersen
  • Konstantinos Palikaras
  • Ioannis Sotiropoulos
  • Jon Storm-Mathisen
  • David C. Rubinsztein
  • Maria Grazia Spillantini
  • Chris I. De Zeeuw
  • Leiv Otto Watne
  • Martin Vyhnalek
  • Katerina Veverova
  • Kristina Xiao Liang
  • Nektarios Tavernarakis
  • Koutaro Yokote
  • Janna Saarela
  • Hilde Nilsen
  • Efstathios S. Gonos
  • Guobing Chen
  • Hisaya Kato
  • Geir Selbæk
  • Tormod Fladby
  • Per Nilsson
  • Anne Simonsen
  • Dag Aarsland
  • Sofie Lautrup
  • Ole Petter Ottersen
  • Lynne S. Cox
  • Evandro F. Fang

Unhealthy aging poses a global challenge with profound healthcare and socioeconomic implications. Slowing down the aging process offers a promising approach to reduce the burden of a number of age-related diseases, such as dementia, and promoting healthy longevity in the old population. In response to the challenge of the aging population and with a view to the future, Norway and the United Kingdom are fostering collaborations, supported by a "Money Follows Cooperation agreement" between the 2 nations. The inaugural Norway-UK joint meeting on aging and dementia gathered leading experts on aging and dementia from the 2 nations to share their latest discoveries in related fields. Since aging is an international challenge, and to foster collaborations, we also invited leading scholars from 11 additional countries to join this event. This report provides a summary of the conference, highlighting recent progress on molecular aging mechanisms, genetic risk factors, DNA damage and repair, mitophagy, autophagy, as well as progress on a series of clinical trials (eg, using NAD+ precursors). The meeting facilitated dialogue among policymakers, administrative leaders, researchers, and clinical experts, aiming to promote international research collaborations and to translate findings into clinical applications and interventions to advance healthy aging.

Original languageEnglish
Article numberglae029
JournalThe journals of gerontology. Series A, Biological sciences and medical sciences
Issue number4
Number of pages10
Publication statusPublished - 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024. Published by Oxford University Press on behalf of The Gerontological Society of America.

    Research areas

  • Aging, Alzheimer’s disease, Dementia, Longevity, Neurodegeneration

ID: 385691584